Regulus Therapeutics Inc.
MicroRNA Compounds and Methods for Modulating MIR-122
Last updated:
Abstract:
Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions.
Status:
Application
Type:
Utility
Filling date:
16 Oct 2020
Issue date:
15 Apr 2021